DAG Assay Kit

DAG Assay Kit
  • Suitable for use with cell lysates
  • Detection sensitivity of 4 µM DAG
  • DAG standard include

NOTE: Each sample replicate requires 2 assays for proper data calculation.

Email To BuyerPrint this PageCopy Link
Ordering

Please contact your distributor for pricing.

DAG (Diacylglycerol) Assay Kit
Catalog Number
MET-5028
Size
100 assays
Detection
Fluorometric
Manual/Data Sheet Download
SDS Download
Price
$460.00
Product Details

Diacylglycerol (DAG) is a glyceride consisting of two fatty acid chains linked by a central glycerol backbone. It is a precursor to lipids such as triglycerides and phospholipids and functions as a second messenger signaling lipid. It is produced through hydrolysis of PIP2 by phospholipase C, which initiates intracellular Ca2+ release and PKC activation. Activated PKC enzymes interact with many different substrates, affecting cellular physiology.

Our DAG (Diacylglycerol) Assay Kit measures diacylglycerol in cell lysate samples by a coupled enzymatic reaction system. First, kinase is used to phosphorylate DAG in samples, yielding phosphatidic acid. Next, lipase is used to hydrolyze phosphatidic acid to glycerol-3-phosphate. The glycerol-3-phosphate product is then oxidized by glycerol-3-phosphate oxidase, producing hydrogen peroxide. The hydrogen peroxide released from this reaction reacts specifically with the kit’s Fluorometric Probe and is detected at ex. 530-560 nm/em. 585-595 nm. DAG levels in unknown samples are determined based on the provided DAG standard curve.

Recent Product Citations
  1. Abe, M. et al. (2024). Bilateral regulation of EGFR activity and local PI(4,5)P2 dynamics in mammalian cells observed with superresolution microscopy. Elife. doi: 10.7554/eLife.101652.
  2. Hu, S. et al. (2024). Atf3-mediated metabolic reprogramming in hepatic macrophage orchestrates metabolic dysfunction-associated steatohepatitis. Sci Adv. 10(30):eado3141. doi: 10.1126/sciadv.ado3141.
  3. Wang, Y. et al. (2024). ApoL6 associates with lipid droplets and disrupts Perilipin1-HSL interaction to inhibit lipolysis. Nat Commun. 15(1):186. doi: 10.1038/s41467-023-44559-3.
  4. Chiang, Y.P. et al. (2021). Sphingomyelin synthases 1 and 2 exhibit phosphatidylcholine phospholipase C activity. J Biol Chem. doi: 10.1016/j.jbc.2021.101398.
  5. Chiang, Y.P. et al. (2021). Sphingomyelin synthase related protein is a mammalian phosphatidylethanolamine phospholipase C. Biochim Biophys Acta Mol Cell Biol Lipids. 1866(11):159017. doi: 10.1016/j.bbalip.2021.159017.
  6. Brekk, O.R. et al. (2020). Cell type-specific lipid storage changes in Parkinson's disease patient brains are recapitulated by experimental glycolipid disturbance. Proc Natl Acad Sci U S A. doi: 10.1073/pnas.2003021117.
  7. Koundouros, N. et al. (2020). Metabolic Fingerprinting Links Oncogenic PIK3CA with Enhanced Arachidonic Acid-Derived Eicosanoids. Cell. doi: 10.1016/j.cell.2020.05.053.
  8. Day, P. et al. (2019). Inhibitors of diacylglycerol metabolism suppress CCR2 receptor signalling in human monocytes. Br J Pharmacol. doi: 10.1111/bph.14695.
  9. Badi, R.M. et al. (2019). Resveratrol protects against hepatic insulin resistance in a rat's model of non-alcoholic fatty liver disease by down-regulation of GPAT-1 and DGAT2 expression and inhibition of PKC membranous translocation. Clin Exp Pharmacol Physiol. doi: 10.1111/1440-1681.13074.
  10. Garcia, D. et al. (2019). Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD. Cell Rep. 26(1):192-208.e6. doi: 10.1016/j.celrep.2018.12.036.
  11. Fanning, S. et al. (2019). Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment. Mol Cell. 73(5):1001-1014.e8. doi: 10.1016/j.molcel.2018.11.028.
  12. Kang, R. et al. (2018). Lipid Peroxidation Drives Gasdermin D-Mediated Pyroptosis in Lethal Polymicrobial Sepsis. Cell Host Microbe. 24(1):97-108.e4. doi: 10.1016/j.chom.2018.05.009.
  13. Tanaka, N., et al. (2017). Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet. Biochim Biophys Acta. pii: S0925-4439(17)30299-5. doi: 10.1016/j.bbadis.2017.08.017.